Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,444 | 667 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,039 | 85 | $0 (2024) |
| ABBVIE INC. | $856.87 | 66 | $0 (2024) |
| PFIZER INC. | $651.82 | 61 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $624.56 | 64 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $552.88 | 39 | $0 (2024) |
| GlaxoSmithKline, LLC. | $500.56 | 35 | $0 (2024) |
| Merck Sharp & Dohme LLC | $386.40 | 33 | $0 (2022) |
| Lilly USA, LLC | $328.06 | 24 | $0 (2024) |
| Amgen Inc. | $309.06 | 20 | $0 (2023) |
| Currax Pharmaceuticals LLC | $285.11 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,563 | 103 | ABBVIE INC. ($261.92) |
| 2023 | $1,010 | 63 | ABBVIE INC. ($196.49) |
| 2022 | $1,054 | 75 | ABBVIE INC. ($164.00) |
| 2021 | $1,093 | 85 | AbbVie Inc. ($181.86) |
| 2020 | $644.63 | 47 | Novo Nordisk Inc ($82.55) |
| 2019 | $896.06 | 75 | PFIZER INC. ($158.64) |
| 2018 | $1,004 | 88 | Janssen Pharmaceuticals, Inc ($176.47) |
| 2017 | $1,179 | 131 | Janssen Pharmaceuticals, Inc ($154.67) |
All Payment Transactions
667 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/09/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $2.83 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: PAIN | ||||||
| 11/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: RESPIRATORY | ||||||
| 10/29/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Obesity | ||||||
| 10/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Diabetes | ||||||
| 10/11/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Neuroscience | ||||||
| 10/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/09/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $3.38 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: PAIN | ||||||
| 10/02/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $9.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: PAIN | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: RESPIRATORY | ||||||
| 09/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Oncology | ||||||
| 09/16/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: RESPIRATORY | ||||||
| 09/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 545 | 1,578 | $158,192 | $68,944 |
| 2022 | 13 | 478 | 1,120 | $102,410 | $54,857 |
| 2021 | 9 | 334 | 735 | $66,105 | $35,996 |
| 2020 | 8 | 355 | 717 | $67,070 | $29,948 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 142 | 444 | $66,665 | $37,153 | 55.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 69 | 374 | $40,644 | $16,755 | 41.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 27 | 102 | $11,571 | $3,645 | 31.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 20 | 66 | $8,066 | $2,408 | 29.9% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 14 | 72 | $7,041 | $2,156 | 30.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 33 | $3,960 | $1,915 | 48.4% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 14 | 37 | $4,935 | $1,329 | 26.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 55 | 55 | $3,025 | $721.60 | 23.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 27 | 72 | $2,520 | $685.44 | 27.2% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 12 | 13 | $780.00 | $527.15 | 67.6% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 12 | 26 | $1,040 | $421.72 | 40.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 31 | $1,240 | $307.73 | 24.8% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 14 | 19 | $965.39 | $264.29 | 27.4% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 25 | 62 | $1,550 | $238.70 | 15.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 32 | 53 | $2,120 | $180.73 | 8.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 18 | 19 | $570.00 | $159.60 | 28.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 19 | 100 | $1,500 | $75.61 | 5.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 142 | 451 | $62,670 | $38,376 | 61.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 68 | 190 | $19,000 | $9,221 | 48.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 32 | 41 | $4,180 | $2,374 | 56.8% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 25 | 28 | $1,680 | $1,142 | 68.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 25 | 55 | $2,200 | $897.36 | 40.8% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 29 | 83 | $2,905 | $795.38 | 27.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 49 | 50 | $2,750 | $661.59 | 24.1% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 14 | 16 | $1,200 | $585.14 | 48.8% |
About Dr. Jennifer Ogle, DO
Dr. Jennifer Ogle, DO is a Family Medicine healthcare provider based in Mount Vernon, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821029729.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jennifer Ogle, DO has received a total of $8,444 in payments from pharmaceutical and medical device companies, with $1,563 received in 2024. These payments were reported across 667 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($8,444).
As a Medicare-enrolled provider, Ogle has provided services to 1,712 Medicare beneficiaries, totaling 4,150 services with total Medicare billing of $189,746. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Mount Vernon, OH
- Active Since 07/06/2006
- Last Updated 01/25/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1821029729
Products in Payments
- CONTRAVE (Drug) $480.37
- XARELTO (Drug) $415.53
- UBRELVY (Drug) $354.79
- Ozempic (Drug) $334.24
- ELIQUIS (Drug) $321.63
- FARXIGA (Drug) $299.74
- TRELEGY ELLIPTA (Drug) $295.93
- JANUVIA (Drug) $236.48
- Vascepa (Drug) $218.73
- NURTEC ODT (Drug) $215.38
- VRAYLAR (Drug) $214.32
- Livalo (Drug) $210.06
- JARDIANCE (Drug) $209.81
- Rybelsus (Drug) $206.22
- XIFAXAN (Drug) $201.76
- Wegovy (Drug) $194.75
- Saxenda (Drug) $184.98
- Trintellix (Drug) $149.33
- ENTRESTO (Drug) $134.08
- INVOKANA (Drug) $133.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Mount Vernon
Dr. Kristen Jacobs, Md, MD
Family Medicine — Payments: $155,452
Ms. Magdalena Gasiorova, M.d, M.D
Family Medicine — Payments: $21,607
Hale Loofbourrow, Md, MD
Family Medicine — Payments: $14,571
Dennon Davis, M.d, M.D
Family Medicine — Payments: $14,139
Brent Ogle, Do, DO
Family Medicine — Payments: $11,204
Dr. Cheryl Williams, D.o, D.O
Family Medicine — Payments: $10,575